MeSH Browser

MeSH Supplementary: dinutuximab
Unique ID: C112746
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C112746
Entry Term(s): APN-311; APN311; CH-14.18; CH-14.18-UTC; CH14.18-UTC; MAb ch14.18; ch14.18; ch14.18 monoclonal antibody; dinutuximab beta; monoclonal antibody ch14.18; unituxin
Pharm Action: Antineoplastic Agents
Registry Number: 7SQY4ZUD30
Heading Mapped to: *Antibodies, Monoclonal
Frequency: 120
Note: a human-mouse chimeric monoclonal antibody directed against disialoganglioside (GD2); used for treatment of refractory neuroblastoma & osteosarcoma
Source: J Clin Oncol 1998 Jun;16(6):2169-80
Date of Entry: 1998/06/30
Revision Date: 2024/03/15

Concept UI: M0291425
Terms: ch14.18 Preferred Term
Term UI T321429
LexicalTag LAB
ThesaurusID NLM (1998); MAb ch14.18
Term UI T321428
LexicalTag LAB
ThesaurusID NLM (1998); CH-14.18-UTC
Term UI T000966146
Date08/22/2019
LexicalTag LAB
ThesaurusID NLM (2020); CH-14.18
Term UI T000966145
Date08/22/2019
LexicalTag LAB
ThesaurusID NLM (2020); monoclonal antibody ch14.18
Term UI T321430
LexicalTag LAB
ThesaurusID NLM (1998); ch14.18 monoclonal antibody
Term UI T794426
Date07/28/2011
LexicalTag LAB
ThesaurusID NLM (2011); CH14.18-UTC
Term UI T000966144
Date08/22/2019
LexicalTag LAB
ThesaurusID NLM (2020)

dinutuximab MeSH Supplementary Concept Data 2024